These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36678516)

  • 1. Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease.
    Aguilera E; Sánchez C; Cruces ME; Dávila B; Minini L; Mosquillo F; Pérez-Díaz L; Serna E; Torres S; Schini A; Sanabria L; Vera de Bilbao NI; Yaluff G; Zolessi FR; Ceilas LF; Cerecetto H; Alvarez G
    Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity.
    Aguilera E; Varela J; Birriel E; Serna E; Torres S; Yaluff G; de Bilbao NV; Aguirre-López B; Cabrera N; Díaz Mazariegos S; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Minini L; Merlino A; Cerecetto H; González M; Alvarez G
    ChemMedChem; 2016 Jun; 11(12):1328-38. PubMed ID: 26492824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment.
    Aguilera E; Varela J; Serna E; Torres S; Yaluff G; Bilbao NV; Cerecetto H; Alvarez G; González M
    Mem Inst Oswaldo Cruz; 2018 Mar; 113(3):153-160. PubMed ID: 29412353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Anti-Parasitic Activity of Arylidene Ketones and Thiazolidene Hydrazines against Trypanosoma cruzi and Leishmania spp.
    Álvarez G; Perdomo C; Coronel C; Aguilera E; Varela J; Aparicio G; Zolessi FR; Cabrera N; Vega C; Rolón M; Rojas de Arias A; Pérez-Montfort R; Cerecetto H; González M
    Molecules; 2017 May; 22(5):. PubMed ID: 28481276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
    da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
    Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
    Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
    Front Immunol; 2020; 11():565142. PubMed ID: 33162979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
    Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
    Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of natural lead molecules as potential
    Tripathi RKP; Dey R; Das N
    Nat Prod Res; 2023 Sep; ():1-5. PubMed ID: 37674430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Analysis of the Secretome and Interactome of
    Watanabe Costa R; Batista MF; Meneghelli I; Vidal RO; Nájera CA; Mendes AC; Andrade-Lima IA; da Silveira JF; Lopes LR; Ferreira LRP; Antoneli F; Bahia D
    Front Immunol; 2020; 11():1774. PubMed ID: 32973747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
    Duschak VG
    Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-H-[1,2]Dithiole as a New Anti-Trypanosoma cruzi Chemotype: Biological and Mechanism of Action Studies.
    Couto M; Sánchez C; Dávila B; Machín V; Varela J; Álvarez G; Cabrera M; Celano L; Aguirre-López B; Cabrera N; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Cerecetto H; González M
    Molecules; 2015 Aug; 20(8):14595-610. PubMed ID: 26274947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists.
    Benítez-Hernández I; Méndez-Enríquez E; Ostoa P; Fortoul T; Ramírez JA; Stempin C; Cerbán F; Soldevila G; García-Zepeda EA
    Immunobiology; 2010 May; 215(5):413-26. PubMed ID: 19581017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
    Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids.
    Aguilera E; Perdomo C; Espindola A; Corvo I; Faral-Tello P; Robello C; Serna E; Benítez F; Riveros R; Torres S; Vera de Bilbao NI; Yaluff G; Alvarez G
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.
    Tempone AG; Ferreira DD; Lima ML; Costa Silva TA; Borborema SET; Reimão JQ; Galuppo MK; Guerra JM; Russell AJ; Wynne GM; Lai RYL; Cadelis MM; Copp BR
    Eur J Med Chem; 2017 Oct; 139():947-960. PubMed ID: 28881289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
    Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
    Front Immunol; 2020; 11():1279. PubMed ID: 32695105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi.
    Planer JD; Hulverson MA; Arif JA; Ranade RM; Don R; Buckner FS
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2977. PubMed ID: 25033456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
    Efstathiou A; Meira CS; Gaboriaud-Kolar N; Bastos TM; Rocha VPC; Vougogiannopoulou K; Skaltsounis AL; Smirlis D; Soares MBP
    Virulence; 2018; 9(1):1658-1668. PubMed ID: 30387370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
    Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
    Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.